Mironid Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Mironid Ltd (Mironid) is a drug discovery company that develops drug candidate molecules. The company offers drug candidate by modulating the activity of key cell signaling proteins for the treatment of degenerative kidney diseases, chronic inflammatory diseases, and cancer. Its drug discovery pipeline includes Novel ShoLo compounds for the treatment of chronic inflammatory diseases; and Novel LoAc compounds for the treatment of degenerative kidney diseases. The company develops a Physiology Mirroring Approach that uses cell signaling to design assays that mirror the drug targets conformation and environment found in living cells. Mironid is headquartered in North Lanarkshire, the UK.

Mironid Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Mironid Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mironid Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mironid Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mironid Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mironid Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mironid Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Mironid Raises USD6.2 Million in Series A Financing 10
Partnerships 12
Mironid Enters into Co-Development Agreement with University of Sheffield 12
Equity Offering 13
Mironid Spin Off from University of Strathclyde 13
Mironid Ltd - Key Competitors 14
Mironid Ltd - Key Employees 15
Mironid Ltd - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Apr 17, 2017: Mironid is delighted to announce the appointment of Dr Alan Lamont as Chief Business Officer (CBO). 17
Jan 05, 2017: Mironid is delighted to announce that Dr George Muller has joined our Scientific Advisory Board 18
Product News 19
01/30/2017: Mironid announces additional non-dilutive funding through an Early Stage Award from Innovate UKs Biomedical Catalyst 2016 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Mironid Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Mironid Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mironid Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mironid Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mironid Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Mironid Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mironid Raises USD6.2 Million in Series A Financing 10
Mironid Enters into Co-Development Agreement with University of Sheffield 12
Mironid Spin Off from University of Strathclyde 13
Mironid Ltd, Key Competitors 14
Mironid Ltd, Key Employees 15

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Mironid Ltd - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Mironid Ltd (Mironid) is a drug discovery company that develops drug candidate molecules. The company offers drug candidate by modulating the activity of key cell signaling proteins for the treatment

USD 250 View Report

Mironid Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mironid Ltd (Mironid) is a drug discovery company that develops drug candidate molecules. The company offers drug candidate by modulating the activity of key cell signaling proteins for the treatment

USD 250 View Report

Vivergo Fuels Ltd - Strategic SWOT Analysis Review

Vivergo Fuels Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report

Merafe Resources Ltd - Strategy, SWOT and Corporate Finance ReportMerafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available